Pharsight

CONCERT PHARMACEUTICALS INC PATENTS FACING OPPOSITIONS

Top patents of CONCERT PHARMACEUTICALS INC facing oppositions at the European Patent Office (EPO)

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP3450434B1 24 Feb, 2021 Deuterated Derivatives Of Ruxolitinib Jun, 2033 1